GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioArctic AB (OSTO:BIOA B) » Definitions » Change In Receivables

BioArctic AB (OSTO:BIOA B) Change In Receivables : kr-1,007 Mil (TTM As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is BioArctic AB Change In Receivables?

BioArctic AB's change in receivables for the quarter that ended in Mar. 2025 was kr-1,007 Mil. It means BioArctic AB's Accounts Receivable increased by kr1,007 Mil from Dec. 2024 to Mar. 2025 .

BioArctic AB's change in receivables for the fiscal year that ended in Dec. 2024 was kr-105 Mil. It means BioArctic AB's Accounts Receivable increased by kr105 Mil from Dec. 2023 to Dec. 2024 .

BioArctic AB's Accounts Receivable for the quarter that ended in Mar. 2025 was kr0 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. BioArctic AB's Days Sales Outstanding for the three months ended in Mar. 2025 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. BioArctic AB's liquidation value for the three months ended in Mar. 2025 was kr599 Mil.


BioArctic AB Change In Receivables Historical Data

The historical data trend for BioArctic AB's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioArctic AB Change In Receivables Chart

BioArctic AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.09 -5.12 -2.41 -11.98 -105.23

BioArctic AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -61.53 - - - -1,007.49

BioArctic AB Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1,007 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioArctic AB  (OSTO:BIOA B) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

BioArctic AB's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/1289.612*91
=0.00

2. In Ben Graham's calculation of liquidation value, BioArctic AB's accounts receivable are only considered to be worth 75% of book value:

BioArctic AB's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=788.566-189.153+0.75 * 0+0.5 * 0
=599

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioArctic AB Change In Receivables Related Terms

Thank you for viewing the detailed overview of BioArctic AB's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


BioArctic AB Business Description

Traded in Other Exchanges
Address
Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.

BioArctic AB Headlines

No Headlines